Tech Company Financing Transactions
NephRx Funding Round
NephRx closed a $3.5 million Series B funding round on 10/13/2008. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/13/2008
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
4717 Campus Drive 100
Kalamazoo, MI 49008
USA
Kalamazoo, MI 49008
USA
Phone
Website
Email Address
Overview
NephRx is a biotechnology company dedicated to the discovery and development of therapeutic products for the treatment of kidney failure/disease, and diseases of the gastrointestinal tract, including mucositis, Crohn's Disease and ulcerative colitis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philip Long
VP - R & D
Ann Berger
Browse more venture capital transactions:
Prev: 10/13/2008: Simbionix USA venture capital transaction
Next: 10/13/2008: Intelligent InSites venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs